Navigation Links
A New Anti-Cancer Drug Keeps Resistance Out

An experimental drug named Dasatinib, developed by Bristol-Myers Squibb company offers a valuable treatment against the signs and symptoms of chronic myeloid leukemia// patients than the usual drug named Gleevec.

Patients, who are resistant to Gleevec drug can now be treated with dasatinib, which seems to regulate intolerance and complications of chronic myeloid leukemic patients - studies published in NEJM finds.

In the phase I clinical trials dasatinib overcome Gleevec resistance in about 68 of 84 patients studied - study leader, HHMI investigator Charles L. Sawyers, and colleagues at UCLA's Jonsson Comprehensive Cancer Center, reported.

People in all 3 stages of the disease such as chronic phase, the accelerated phase, and blast crisis respond to the new drug quite possibly, Sawyers says.

Sawyers said, ‘Drug-related mutations are better understood by the application of experimental drug, dasatinib to subjects and even individual patient’s mutation type were easily studied by scientists at Bristol-Myers Squibb’.

‘How drug target mutation take place and whether molecular explanation of drugs has any role to play in it’ all studied by the scientists, showing improvements in structural biology studies.

Due to being as a ‘sloppier inhibitor’ meaning - does not hold its target to such tight structural constraints, dasatinib differs from the drug Gleevec.

Sawyers added dasatinib proves its value to overcome kinase resistance in managing cancer patients and also keep rooting in other fields of medicine like molecular oncology and structural biology.
'"/>




Page: 1

Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. FDA Approves Anti-Cancer Cell Drug - Zevalin
3. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
4. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
5. Antidepressant Drug Found To Have Anti-Cancer Effects
6. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Exercise Has An Anti-Cancer Effect
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Anti Cancer Drug Keeps Resistance Out

(Date:12/2/2008)...tCall/ -- Quest Diagnostics Incorporated (NYSE: ...testing, information and services, announced that ...thcare Conference in New York City today, December...cheduled to begin at 4:00 p.m. Eastern Time. , ...affirm its 2008 guidance for revenue growth of gre...
(Date:12/2/2008)...er with aprotinin, a drug commonly used to control...y, compared with lysine analogues, according to a ...9 to be published in the January 20th issue of C...dvisory panel will meet to decide on aprotinin use...the meeting. , The study, a systematic review o...
(Date:12/2/2008)...rstCall/ - NUCRYST Pharmaceuticals Corp., a develo...t infection and inflammation, announced today that...rity shareholder, The Westaim Corporation ("Westai...areholders to consider a return of capital of US$0...s to a return of capital of approximately US$15 mi...
(Date:12/2/2008)...e Efficacy of Commercially Available Hypomethylati... Eisai Corporation of North Americ...rst clinical trial evaluating the activity of Daco...za(R) (azacitidine) in adult patients with interme...ic syndromes (MDS), a potentially life-threatening...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3
... the researchers at the McMaster University includ...till remains controversial.// Sports drink play a...s carbohydrates and sodium. Carbohydrates provide ...ntains fluid balance in the body. The study, which...
...ave discovered that fibrin fibers could stretch to...riginal state, while some could even stretch to si...Fibrin involved in blood clotting is developed in ...inogen. When an injury occurs fibrin is deposited...
...iday banned the sale and consumption of soft drink...e have imposed a ban on soft drinks in all educati...an Education Minister Ghanshyam Tiwari told IANS h...o 100,000 government and private institutes where ...
... popular supermarket chains have announced that th...in their products.// Trans fat was recently in th...rt diseases. It is also thought to cause cancers a... are Sainsbury, Asda and Tesco. It was found that ...
Other Medicine News:Health News:Is Addition Of Proteins In The Sports Drink Beneficial? 2
(Date:12/1/2008)..., Dec. 1 Vical Incorpora...of a $1.0 million milestone payment from Merck &am...f a Phase I clinical trial of an investigational p...ccine is based on Vical,s DNA gene delivery techno...ptase (hTERT). hTERT is the subject of separate li...
(Date:11/28/2008)...ITZ, Germany, November 28 German b...dership in specialized HIV monitoring and,AIDS pa...rging countries. In,the year 2008, 2.5 million pa..., robust and highly affordable "CyFlow" system, su...g with HIV/AIDS. Due to introduction of the,Parte...
(Date:11/26/2008)..., Minn., Nov. 26 Childr... at significantly increased risk of developing men...ngs of a Mayo Clinic study published this month i...n Academy of Pediatrics. , , The retrospect...ents with strabismus (misaligned eyes) and compare...
(Date:11/25/2008)...wareness can improve recovery , , Audio and...vailable on the Mayo Clinic News Blog. Please see ... , ROCHESTER, Minn., Nov. 25 /PRNewswire-USNews...troke patients don,t think they,re having a stroke...il their condition worsens. The findings appear in...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3SuperGens MP 470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 8500 1SuperGens MP 470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 8500 2SuperGens MP 470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 8500 3SuperGens MP 470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 8500 4Laboratory Pumping Systems to Reach 243 1 Billion by 2012 According to New Report by Global Industry Analysts Inc 8497 1Laboratory Pumping Systems to Reach 243 1 Billion by 2012 According to New Report by Global Industry Analysts Inc 8497 2Laboratory Pumping Systems to Reach 243 1 Billion by 2012 According to New Report by Global Industry Analysts Inc 8497 3Virgin Active Says Leave the Cleavage to the Girls 27659 1Virgin Active Says Leave the Cleavage to the Girls 27659 2Depression during pregnancy can double risk of preterm delivery 5533 1Depression during pregnancy can double risk of preterm delivery 5533 2
...e BP monitor is designed to automatically measure ...BP along with heart rate. It's a Blood Pressure mo...ergometer and pharmacological stress test environm...ronments., ,Tango excels where other BP monit...
BD Visiswab Cotton Swab
...l, Philips Zymed 1810 Series offers retrospective ... the operator the flexibility to adjust the algori...application beyond the basic 1810 and you have eve...matic style that best meets the challenges of each...
...s STG for PC captures, displays, replays and analy...be effective in evaluating heart illnesses, pneumo...ase.,It provides objective evidence as a complem...time-expanded waveform displays, Phonocardiogra...
Medicine Products: